Acute Lymphoblastic Leukemia (ALL)

DBCOND0031335Hemic and Lymphatic DiseasesImmune System Diseases

Acute Lymphoblastic Leukemia (ALL) is the indication for 13 drugs in DrugBank. It is covered by 17 curated, structured indications.

Also known as
Acute Lymphoblastic Leukemia · Acute Lymphoblastic Leukemias · Acute Lymphoblastic Leukaemia · Acute Lymphoblastic Leukaemias (ALL) · ALL (Acute Lymphoblastic Leukemia)
Classified under
Indicated drugs

Resolves to

Vocabularies
MeSHM0502706ICD-10C91.0SNOMED CT128822004MedDRA10024290UMLSC0023449

What you can answer from here — as of September 26, 2026

13Indicated drugsWith each drug's targets and mechanism
Listed above
17Structured indicationsPopulation, line of therapy, route and combination as fields, not prose
Sign in
1,061Clinical trialsPhase, status and sponsor resolved per trial
Sign in
7Drugs reporting it as an adverse effectWith incidence where the label states it
Sign in

Which approved drugs for Acute Lymphoblastic Leukemia (ALL) share a target, and which companies have late-stage candidates against it?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In